CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
5.32
+0.08 (1.62%)
At close: Oct 2, 2026, 4:00 PM EDT
5.45
+0.13 (2.35%)
After-hours: Oct 2, 2026, 7:30 PM EDT
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $7.78 million as of October 2, 2026. Its market cap has increased by 55.67% in one year.
Market Cap
7.78M
Enterprise Value
-12.20M
1-Year Change
55.67%
Ranking
Category
Stock Price
$5.32
ChartMarket Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $7.78M, a decrease of -88.87%. That is a compound annual growth rate of -27.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 7.78M | 138.96% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 8.23M |
| XTL Biopharmaceuticals | 8.16M |
| Azitra | 8.00M |
| Soligenix | 7.95M |
| Enlivex | 7.71M |
| Ensysce Biosciences | 7.69M |
| Exicure | 7.53M |
| KALA BIO | 7.45M |